Eli Lilly Threatens 340B Hospitals Over Data Deadline
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Eli Lilly warned roughly 50 340B hospitals to submit comprehensive claims data within five days or lose their mandated price breaks, per STAT.
- Eli Lilly reports that while over 2,300 hospitals have complied, up to 1,000 hospitals—especially larger systems—have not submitted the required data since the Feb. 1 policy took effect.
- U.S. FDA will hold a closed‑door roundtable on Wednesday with at least 10 rare‑disease advocacy groups and senior agency officials, including Acting Commissioner Kyle Diamantas, to discuss advancing treatments that face regulatory hurdles.
Why it matters: Hospitals missing the five‑day deadline risk losing 340B price discounts, squeezing margins, while the FDA’s rare‑disease roundtable gives advocacy groups a direct line to regulators to discuss advancing treatments.
